SEC Form 4 · accession 0000891293-15-000023
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Global Medical Affairs · Director
Period of report
Jun 26, 2015
Accepted (ET)
Jun 26, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2015 | S | 400 | $2.04 | D | 1,305,519 | D | |
| Common Stock | Jun 26, 2015 | S | 400 | $2.045 | D | 1,305,119 | D | |
| Common Stock | Jun 26, 2015 | S | 1,200 | $2.05 | D | 1,303,919 | D | |
| Common Stock | Jun 26, 2015 | S | 100 | $2.055 | D | 1,303,819 | D | |
| Common Stock | Jun 26, 2015 | S | 3,500 | $2.06 | D | 1,300,319 | D | |
| Common Stock | Jun 26, 2015 | S | 4,300 | $2.065 | D | 1,296,019 | D | |
| Common Stock | Jun 26, 2015 | S | 2,200 | $2.07 | D | 1,293,819 | D | |
| Common Stock | Jun 26, 2015 | S | 500 | $2.075 | D | 1,293,319 | D | |
| Common Stock | Jun 26, 2015 | S | 200 | $2.08 | D | 1,293,119 | D | |
| Common Stock | Jun 26, 2015 | S | 100 | $2.09 | D | 1,293,019 | D | |
| Common Stock | Jun 26, 2015 | S | 1,200 | $2.10 | D | 1,291,819 | D | |
| Common Stock | Jun 26, 2015 | S | 200 | $2.105 | D | 1,291,619 | D | |
| Common Stock | Jun 26, 2015 | S | 700 | $2.11 | D | 1,290,919 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a Rule 10b5-1 trading plan.